About Barinthus Biotherapeutics plc (BRNS) data
Data as of August 31, 2026.
Barinthus Biotherapeutics plc (BRNS) has 13.21K shares sold short as of the latest FINRA settlement report on August 31, 2026. Short interest has increased by 46.19% compared with the prior settlement. At the current average daily volume, covering all open short positions would take about 0.26 days (days to cover).
Frequently asked questions
What is the current short interest in BRNS?
As of the latest FINRA settlement dated August 31, 2026, BRNS had approximately 13,211 shares sold short. Short interest data is reported by FINRA twice per month.
How much does it cost to short BRNS?
The latest borrow fee (cost to borrow) for BRNS is 4.17% per year, based on IBKR data. Fees can change throughout the trading day as shares are borrowed and returned.
What is the days to cover ratio for BRNS?
Days to cover for BRNS is approximately 0.26 days. This estimates how many trading days it would take short sellers to buy back all outstanding short shares at the current average daily volume.
Is BRNS a short squeeze candidate?
A squeeze needs shorts that are hard to close. BRNS trades about 51,265 shares a day and would take roughly 0.26 days to unwind current short positions, at a current borrow fee of 4.17%. Higher days-to-cover and a rising borrow fee together are the setup to watch; neither alone is enough.